Bank of New York Mellon’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15K | Hold |
|
|||||
|
2025
Q2 | $12.1K | Hold |
|
|||||
|
2025
Q1 | $14.6K | Hold |
|
|||||
|
2024
Q4 | $22.7K | Buy |
|
|||||
|
2024
Q3 | $12.6K | Hold |
|
|||||
|
2024
Q2 | $5.2K | Sell |
|
|||||
|
2024
Q1 | $317K | Sell |
|
|||||
|
2023
Q4 | $270K | Sell |
|
|||||
|
2023
Q3 | $301K | Sell |
|
|||||
|
2023
Q2 | $663K | Buy |
|
|||||
|
2023
Q1 | $880K | Buy |
|
|||||
|
2022
Q4 | $1.56M | Sell |
|
|||||
|
2022
Q3 | $2.52M | Buy |
|
|||||
|
2022
Q2 | $1.91M | Buy |
|
|||||
|
2022
Q1 | $2.58M | Buy |
|
|||||
|
2021
Q4 | $3.29M | Buy |
|
|||||
|
2021
Q3 | $3.93M | Buy |
|
|||||
|
2021
Q2 | $4.85M | Sell |
|
|||||
|
2021
Q1 | $6.14M | Sell |
|
|||||
|
2020
Q4 | $7.93M | Sell |
|
|||||
|
2020
Q3 | $5M | Sell |
|
|||||
|
2020
Q2 | $4.87M | Buy |
|
|||||
|
2020
Q1 | $3.28M | Buy |
|
|||||
|
2019
Q4 | $4.26M | Sell |
|
|||||
|
2019
Q3 | $4.63M | Buy |
|
|||||
|
2019
Q2 | $5.44M | Buy |
|
|||||
|
2019
Q1 | $4.48M | Buy |
|
|||||
|
2018
Q4 | $5.32M | Buy |
|
|||||
|
2018
Q3 | $7.71M | Buy |
|
|||||
|
2018
Q2 | $6.35M | Sell |
|
|||||
|
2018
Q1 | $8.81M | Buy |
|
|||||
|
2017
Q4 | $6.44M | Buy |
|
|||||
|
2017
Q3 | $5.61M | Buy |
|
|||||
|
2017
Q2 | $2.99M | Buy |
|
|||||
|
2017
Q1 | $1.73M | Buy |
|
|||||
|
2016
Q4 | $958K | Sell |
|
|||||
|
2016
Q3 | $1.46M | Sell |
|
|||||
|
2016
Q2 | $19.3M | Sell |
|
|||||
|
2016
Q1 | $20.3M | Buy |
|
|||||
|
2015
Q4 | $17.3M | Sell |
|
|||||
|
2015
Q3 | $11M | Buy |
|
|||||
|
2015
Q2 | $20.8M | Buy |
|
|||||
|
2015
Q1 | $27.8M | Buy |
|
|||||
|
2014
Q4 | $23.8M | Buy |
|
|||||
|
2014
Q3 | $3.95M | Sell |
|
|||||
|
2014
Q2 | $5.63M | Buy |
|
|||||
|
2014
Q1 | $6.33M | Buy |
|
|||||
|
2013
Q4 | $4.42M | Buy |
|
|||||
|
2013
Q3 | $2.94M | Buy |
|
|||||
|
2013
Q2 | $2.04M | Buy |
|